![Crystal and molecular structure of (5S,8aS,9S)-9-hydroxy- 5-methyl- 4,6,7,8,8a,9-hexahydrothieno-[ 3,2-f] indolizin-5-ium iodide Cover](https://sciendo-parsed.s3.eu-central-1.amazonaws.com/6470799b71e4585e08a9e01d/cover-image.jpg)
References
- Allen FH, Johnson O, Shields GP, Smith BR, Towler M (2004) J. Appl. Cryst. 37: 335-338.
- Brandenburg K (2001) DIAMOND Version 2.1e. Crystal Impact GbR, Bonn, Germany.
- Cremer D, Pople JA (1975) J. Am. Chem. Soc. 97: 1354-1362.
- Farrugia LJ (1999) J. Appl. Cryst. 30: 565.
- Flack HD (1983) Acta Cryst. A39: 876-881.
- Gubin J, Lucchetti J, Mahaux J, Nisato D, Rosseels G, Clinet M, Polster P, Chatelain P (1992) J. Med. Chem. 35: 981-988.
- Gundersen LL, Charnock C, Negussie AH, Rise F, Teklu S (2007) Eur. J. Pharm. Sci. 30: 26-35.
- Gupta SP, Mathur AN, Nagappa AN, Kumar D, Kumaran S (2003) Eur. J. Med. Chem. 38: 867-873.
- Mikael JP (1999) Nat. Prod. Rep. 16: 675-709.
- Oxford Diffraction (2009). CrysAlisPro. Oxford Diffraction Ltd, Abingdon, Oxfordshire, England.
- Sheldrick GM (2008) Acta Cryst. A64: 112-122.
- Pyne SG (2005) Curr. Org. Synth. 2: 39-57.
- Spek AL (2009) Acta Cryst. D65: 148-155.
- Šafař P, Žužiova, J, Marchalin Š, Pronayova N, Švorc Ľ, Vrabel V, Šestak S, Rendič D, Tognetti V, Joubert L, Daich A (2012) Eur. J. Org. Chem. 5498-5514.
- Teklu S, Gundersen LL, Larsen T, Malterud KE, Rise F (2005) Med. Chem. 13: 3127-3139.